POC Prescribing Guidelines
The Prescribing Oversight Committee is a Berkshire West Integrated Care Partnership committee representing Primary and Secondary Care across West Berkshire
Prescribing Oversight Committee - Prescribing Guidelines
IMPORTANT INFORMATION
This website is no longer being updated.
Berkshire West Clinical Commissioning Group has been legally dissolved and from 1 July 2022 has been replaced by a new organisation: Buckinghamshire, Oxfordshire & Berkshire West Integrated Care Board (BOB ICB). BOB ICB is now responsible for the commissioning and funding of health and care services locally. Please go to our new website www.bucksoxonberksw.icb.nhs.uk for information about the work of BOB ICB and details about how to contact us.
POC Documents still remain applicable to Berkshire West until they are reviewed over time to align the position across the BOB locality.
Please see the BW Formulary for the most up-to-date position.
Please click here to go back to the POC Documents Homepage
- POC (APC) PG 001 - For the treatment and prevention of Venous Thromboembolic disease (DVT/PE)
- POC (APC) PG 002 - Azathioprine/6-Mercaptopurine for the treatment of Inflammatory Bowel Disease (IBD)
- APC PG 003 - Azathioprine for the treatment of inflammatory joint disease superseded by APC PG 037 (see below)
- APC PG 004 - Ciclosporin for the treatment of inflammatory joint disease superseded by APC PG 037 (see below)
- POC (APC) PG 005 - Cinacalcet for the treatment of secondary hyperparathyroidism
- POC (APC) PG 006 - Denosumab for the treatment of osteoporosis in men and postmenopausal women at increased risk of fractures
- POC (APC) PG 007 - Fidaxomicin for the treatment of recurrent Clostridium difficile infection (CDI) replaced by NICE NG 199
- APC PG 008 - Gold therapy for the treatment of inflammatory joint disease superseded by APC PG 037 (see below)
- APC PG 009 - Leflunomide for the treatment of inflammatory joint disease superseded by APC PG 037 (see below)
- POC (APC) PG 010a - Lithium Prescribing Arrangements
- POC (APC) PG 012 - BHFT Methadone for refractory pain
- POC (APC) PG 013 - Mycophenolate mofetil (MMF) for the treatment of inflammatory joint disease
- POC (APC) PG 014 - Non-calcium based binders Lanthanum Carbonate and Sevelamer Carbonate or Hydrochloride for the treatment of hyperphosphatemia in adults with chronic kidney disease
- POC (APC) PG 015a - Cholinesterase Inhibitors / Memantine Prescribing Arrangements
- POC (APC) PG 016 - Prescribing Arrangements for Patients Prescribed Long Acting Injectable (LAI) Antipsychotics
- POC (APC) PG 017 - Primary care prescribing arrangements for midodrine (Bramox®) for use in orthostatic hypotension and Postural Tachycardia Syndrome (PoTS)
- POC (APC) PG 018 - Methotrexate for the treatment of Inflammatory Bowel Disease
- POC (APC) PG 019 - Mycophenolate Mofetil for the treatment of lupus nephritis and systemic vasculitis
- POC (APC) PG 020 - Sacubitril valsartan for the treatment of symptomatic heart failure
- POC (APC) PG 021 - Prescribing Guideline for amantadine for the treatment of fatigue in Multiple Sclerosis
- POC (APC) PG 022 - Azathioprine for the treatment of vasculitis
- POC (APC) PG 023 - Methotrexate for the treatment of vasculitis
- POC (APC) PG 024 - Tacrolimus for the treatment of Nephrotic Syndrome
- APC PG 025 - Rheumatology Department DMARD Monitoring Guidelines for Methotrexate superseded by POC (APC) PG 037 (see below)
- POC (APC) PG 026 - Hydroxycarbamide for Polycythaemia Vera, Myelofibrosis and Essential Thrombocythaemia
- POC (APC) PG 027 - Nebulised tobramycin for the treatment Pseudomonas colonised (non cystic fibrosis) bronchiectasis, intolerant of, or deterioration on, long term nebulised Colomycin
- POC (APC) PG 028 - Nebulised colomycin for the treatment Pseudomonas colonised (non cystic fibrosis) bronchiectasis
- POC (APC) PG 029 - Human Growth Hormone (somatropin)
- POC (APC) PG 030 - The use of GnRH Agonists in Central Precocious Puberty (CPP)
- POC (APC) PG 031 - Topical tacrolimus (Protopic) for the treatment of moderate to severe atopic dermatitis in adults not responding to conventional therapies
- POC (APC) PG 032 - Tinzaparin for Prophylaxis of Venous Thromboembolism during Pregnancy and the Puerperium
- POC (APC) PG 033 - Tacrolimus for the treatment of Inflammatory Bowel Disease (IBD)
- POC (APC) PG 034 - Sucroferric Oxyhydroxide for hyperphosphataemia in adults with chronic kidney disease
- POC (APC) PG 037 - DAWN Prescribing Guideline Process Summary
- POC (APC) PG 038 - Liothyronine for a selected cohort of adults with Hypothyroidism